Amy Meacham

1.1k total citations
16 papers, 724 citations indexed

About

Amy Meacham is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Amy Meacham has authored 16 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Amy Meacham's work include Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Amy Meacham is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Amy Meacham collaborates with scholars based in United States, India and Poland. Amy Meacham's co-authors include Naohiro Terada, Takashi Hamazaki, Masahiro Oka, Leonard I. Zon, Philip J. Papst, Christopher R. Cogle, Edward W. Scott, Nemanja Rodić, Lung‐Ji Chang and Masahiro Oka and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Amy Meacham

16 papers receiving 707 citations

Peers

Countries citing papers authored by Amy Meacham

Since Specialization

Citations

This map shows the geographic impact of Amy Meacham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Meacham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Meacham more than expected).

Fields of papers citing papers by Amy Meacham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Meacham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Meacham. The network helps show where Amy Meacham may publish in the future.

Co-authorship network of co-authors of Amy Meacham

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Meacham. A scholar is included among the top collaborators of Amy Meacham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Meacham. Amy Meacham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies 2020 ·Cellular Reprogramming ·(unknown), (unknown), Katherine E. Santostefano, (unknown), (unknown), Coy D. Heldermon, Daisuke Tachibana, Masayasu Koyama, Amy Meacham, Christina A. Pacak, Naohiro Terada	4
2	CRISPR Dropout Screens Identify DHODH,PIK3C3, and Crkl as Potential Therapeutic Targets in Acute Myeloid Leukemia 2019 ·Blood ·(unknown), Yujia Zhou, David King, Amy Meacham, (unknown), Abderrahmane Tagmount, Amin Sobh, (unknown), Chris D. Vulpe, Christopher R. Cogle	2
3	Exploring the Structure–Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells 2018 ·Journal of Medicinal Chemistry ·Tengfei Bian, (unknown), Yi Wang, Amy Meacham, Santanu Hati, Christopher R. Cogle, Haifeng Sun, Chengguo Xing	14
4	Chemosensitizing AML cells by targeting bone marrow endothelial cells 2016 ·Experimental Hematology ·(unknown), (unknown), Amy Meacham, Elizabeth Wise, Leylah Drusbosky, Glenn A. Walter, David J. Chaplin, Dietmar W. Siemann, Daniel L. Purich, Christopher R. Cogle	19
5	Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells 2016 ·Cytotherapy ·Nancy Villa, (unknown), Winnie Chan, Amy Meacham, Elizabeth Wise, Masmudur M. Rahman, Jan S. Moreb, (unknown), John R. Wingard, Grant McFadden, Christopher R. Cogle	21
6	Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells 2015 ·Blood ·Nancy Villa, Clive Wasserfall, Amy Meacham, Elizabeth Wise, Winnie Chan, John R. Wingard, Grant McFadden, Christopher R. Cogle	33
7	Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition 2015 ·Leukemia Research ·Leylah Drusbosky, Eric J. Gars, Angelica Trujillo, (unknown), Amy Meacham, Elizabeth Wise, Edward W. Scott, Christopher R. Cogle	21
8	Functional integration of acute myeloid leukemia into the vascular niche 2014 ·Leukemia ·Christopher R. Cogle, (unknown), Gerard J. Madlambayan, Ronald P. Leon, Azzah Al Masri, Helen Clark, (unknown), Jeffrey Tyner, (unknown), Gaofeng Fan, Tibor Kovacsovics, Qianshi Liu, Amy Meacham, (unknown), Robert Hromas, Edward W. Scott, Will Fleming	68
9	A Phase I Study Of The Vascular Disrupting Combretastatin, OXi4503, In Patients With Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) 2013 ·Blood ·Daniel Turner, Andrés González, (unknown), Amy Meacham, Elizabeth Wise, (unknown), D J Chaplin, Jack W. Hsu, Randy A. Brown, John W. Hiemenz, Maxim Norkin, John R. Wingard, Christopher R. Cogle	9
10	Bone Marrow Endothelial Cells Protect Acute Myeloid Leukemia From Chemotherapy By Direct Contact: The BCAM/Laminin/VLA5 Axis As a Potential Therapeutic Target 2013 ·Blood ·Leylah Drusbosky, Amy Meacham, Elizabeth Wise, Edward W. Scott, Christopher R. Cogle	6
11	Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells 2012 ·PLoS ONE ·Eric Bartee, Amy Meacham, Elizabeth Wise, Christopher R. Cogle, Grant McFadden	14
12	Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro 2012 ·Leukemia Research ·Gerard J. Madlambayan, Eric Bartee, (unknown), Masmudur M. Rahman, Amy Meacham, Edward W. Scott, Grant McFadden, Christopher R. Cogle	20
13	Leukemia regression by vascular disruption and antiangiogenic therapy 2010 ·Blood ·Gerard J. Madlambayan, Amy Meacham, Koji Hosaka, (unknown), (unknown), Edward W. Scott, Dietmar W. Siemann, Christopher R. Cogle	59
14	Acute Myeloid Leukemia Cells Depend on VEGF, PDGFR and SCF Receptor Signaling: Leukemia Regression with Pazopanib. 2010 ·Blood ·Eric J. Gars, (unknown), (unknown), Elizabeth Wise, Amy Meacham, Christopher R. Cogle	2
15	De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine 2005 ·Oncogene ·Masahiro Oka, Amy Meacham, Takashi Hamazaki, Nemanja Rodić, Lung‐Ji Chang, Naohiro Terada	104
16	Hepatic maturation in differentiating embryonic stem cells in vitro 2001 ·FEBS Letters ·Takashi Hamazaki, (unknown), Masahiro Oka, Philip J. Papst, Amy Meacham, Leonard I. Zon, Naohiro Terada	328

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact